126-30-7
CAS 126-30-7
126-30-7 (CAS 126-30-7) is a pharmaceutical compound with 0 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| NEOPENTYL GLYCOL | 1368162 | SU | MTHSPL |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is 126-30-7 used for in pharmaceutical contexts?
126-30-7 (CAS 126-30-7) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for 126-30-7?
No adverse-event association or SIDER side-effect rows are rendered for 126-30-7 in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is 126-30-7 also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for NEOPENTYL GLYCOL with EU status "permitted".
What clinical phase is 126-30-7 in?
No phase 1-4 clinical development badge is rendered for 126-30-7 because the matched compound identifier rows do not contain a max-phase value.